Cas:877264-77-2 tert-Butyl 6-bromo-1H-indazole-1-carboxylate manufacturer & supplier

We serve Chemical Name:tert-Butyl 6-bromo-1H-indazole-1-carboxylate CAS:877264-77-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

tert-Butyl 6-bromo-1H-indazole-1-carboxylate

Chemical Name:tert-Butyl 6-bromo-1H-indazole-1-carboxylate
CAS.NO:877264-77-2
Synonyms:2-Methyl-2-propanyl 6-bromo-1H-indazole-1-carboxylate;1H-Indazole-1-carboxylic acid, 6-bromo-, 1,1-dimethylethyl ester;1-Boc-6-bromo-1H-indazole;1-BOC-6-BROMO-INDAZOLE;1-([1,1-dimethylethyl]oxycarbonyl)-6-bromoindazole;6-Bromo-1H-indazole,N1-BOC protected;tert-Butyl 6-bromo-1H-indazole-1-carboxylate;1,1-dimethylethyl 6-bromo-1H-indazole-1-carboxylate
Molecular Formula:C12H13BrN2O2
Molecular Weight:297.148
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:377.4±34.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.599
PSA:44.12000
Exact Mass:296.016022
LogP:3.88

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-Methyl-2-propanyl 6-bromo-1H-indazole-1-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,1-dimethylethyl 6-bromo-1H-indazole-1-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-BOC-6-BROMO-INDAZOLE Use and application,1H-Indazole-1-carboxylic acid, 6-bromo-, 1,1-dimethylethyl ester technical grade,usp/ep/jp grade.


Related News: Natural Biogenex, a 100 per cent subsidiary of Natural Capsules, is speeding up its efforts to manufacture active pharmaceutical ingredients (APIs) following the recent grant from Union government’s production linked incentive (PLI) scheme to offset the import dependence. 1H-Indole-3-carboxamide, 6-methoxy-1-(1-methylethyl)-N-2-thiazolyl- manufacturers ICER’s researchers used a two-year treatment horizon in their model but noted that it’s unclear how long patients are supposed to remain on these treatments. The model may not fully capture the challenges the disease presents to patients, ICER acknowledged. D-Glutamic acid, N-(7-nitro-2,1,3-benzoxadiazol-4-yl)- suppliers These studies have revealed a high rate of success among many of its compounds (see Mindset’s news release of April 29, 2021), giving Mindset an exceptional pool of new drug candidates from which it will continue to identify additional suitable compounds. 1-[Phenyl-(toluene-4-sulfonyl)-p-tolyl-methyl]-naphthalene vendor & factory.